Osteoarthritis, Knee Clinical Trial
Official title:
Postoperative Oedema Management Following Neuromuscular Electro- Stimulation of the Peroneal Nerve Using the gekoTM Device After Total Knee Arthroplasty
Verified date | April 2022 |
Source | moveUP bv |
Contact | Ward Servaes |
Phone | +32 800 88 008 |
support[@]moveup.care | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will investigate whether the recovery of muscle function of total knee arthroplasty is accelerated with the use of the gekoTM device along with its effect on reducing symptoms such as oedema and inhibition of the muscle function.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | November 2023 |
Est. primary completion date | July 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - Primary TKA planned for degenerative OA - Subjects must be discharged to home environment and be able to independently perform the activities of daily life - Obtain a written informed consent Exclusion Criteria: - TED stockings, Dauerbinde, other compressive bandages - Mechanical foot pump - Cooling device type 'Game Ready' - Posttraumatic OA of the knee - History of DVT / Flebitis / Pulmonary embolism - Surgical treatment of venous insufficiency <1y prior to TKA surgery - Neurological deficit of lower limbs - Current sciatic irradiating pain in lower limbs - History of lumbar fusion - Knee Arthroscopy of the involved limb <6m prior to TKA surgery - Any per-operative complication related to the TKA procedure (bleeding, fracture, vascular injury, cardiac complication, pulmonary complication) - In case of a release during the TKA procedure - Any per-operative (e.g. epidural catheter, urethral catheter, intra articular catheter) or post-operative procedure that might interfere with the rehabilitation during and after hospitalization - Any scheduled surgery in the 3 months following the reference surgery; - Any significant medical condition (e.g. Parkinson's disease, multiple sclerosis, cerebral vascular accident) that might interfere with the rehabilitation - Any significant psychiatric disorders, active alcohol/drug abuse - Subject is either pregnant or interested in becoming pregnant during the duration of the study - Subjects who are currently involved in any investigational drug or device study or have been enrolled in such study within the last 3 months |
Country | Name | City | State |
---|---|---|---|
Belgium | AZ maria middelares | Ghent | East-Flanders |
Lead Sponsor | Collaborator |
---|---|
moveUP bv | Firstkind Ltd |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The primary objective of the study is to assess the post-operative effect of gekoTM on formation of oedema following Total Knee Arthroplasty (TKA) | This is measured by the use of a perometer. For each patient, change in limb volume shall be calculated as a percentage of original limb volume.
Shapiro-Wilk test shall be used to test whether there is a significant (p<0.05) departure from normal distribution in either group. |
until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Incidence of Adverse Events | Any untoward medical occurrence, unintended disease or injury or any untoward clinical signs, including an abnormal laboratory finding, in subjects, users or other persons, in the context of a clinical investigation, whether or not related to the investigational device.
(MDR Article 2(57)). The total number adverse events and the total number (%) of patients that had at least 1 adverse event will be stated. |
until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Incidence of Device Deficiency | Any inadequacy in the identity, quality, durability, reliability, safety or performance of an investigational device, including malfunction, use errors or inadequacy in information supplied by the manufacturer.(MDR Article 2(59)) | during 10 days after TKA operation | |
Secondary | Oedema measurements - subjective slider | Temperature/swelling: Identical subjective slider as daily evaluated by the patient itself presenting the result as a Visual Analog Scale score, minimum 0 (no swelling) maximum 100 (Very swollen) | until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Oedema measurements - photographic evaluation | picture of both knees (moveUP): Patients need to make a picture of both knees, using the photo camera on their smartphone to see the swelling of the operated leg compared to the non-operated leg and to evaluate the swelling of the operated leg.
This blind assessment of pictures is performed by a physical therapist. |
until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Patient Reported Outcome Measures (PROM's) | The PROMS's measured:
- KOOS: Knee injury and Osteoarthritis Outcome Score for Joint Replacement. 42 items on 5-point Likert scale (multiple choice), total score is on 100, lower scores being indicative of worse knee conditions and higher scores being indicative of better knee condition |
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Patient Reported Outcome Measures (PROM's) | The PROMS's measured:
- KSS: Knee Satisfaction Score. Multiple choice scale. Total score on 100, lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions. |
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Patient Reported Outcome Measures (PROM's) | The PROMS's measured:
- EQ5-D: Euroqol Health questionnaire. 5 items on 5-point Likert scale (multiple choice). Total score on 100. Secondly there is also 1 visual analog scale (VAS). The VAS Score is scored separately with lower scores being indicative of worse health and higher scores being indicative of better health (generic questionnaire, not disease specific) |
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Patient Reported Outcome Measures (PROM's) | The PROMS's measured:
- OKS: Oxford Knee Score. 12 items Multiple choice. a lower score can be indicative for bad function or pain after TKA |
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Patient Reported Outcome Measures (PROM's) | The PROMS's measured:
- FJS: Forgotten Joint score. 12-item mutiple choice score. Total score on 100 (%), lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions. |
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Pain level | Visual analogue scale (VAS), a 0-100 scale with 100 score = the worst pain the patient can feel and 0 = the patient feels no pain | 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Number of days of Painkiller intake | PK intake stop is defined as no PK consumption for 3 consecutive days with no new 3 day-period of PK intake. | 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Dosage Painkiller intake | 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | ||
Secondary | Number of days of NSAID intake | NSAID intake stop is defined as no NSAID consumption for 3 consecutive days with no new 3 day-period of NSAID intake. | 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Dosage NSAID intake | 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | ||
Secondary | Sleep duration | the wearable measures accelerations during 23h-8h and gives an assumption duration of sleep during the night. The assumption of amount of sleep is based on: very little registration (deep sleep), little movements (light sleep), a lot of movements (waking up). | 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Sleep quality | the wearable measures accelerations during 23h-8h and gives an assumption quality of sleep during the night. The assumption of amount of sleep is based on: very little registration (deep sleep), little movements (light sleep), a lot of movements (waking up). | 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Recovery of physical activity (PA) | number of weeks until post-operative PA level is similar to pre-operative PA level, meaning there is no significant difference between mean post-operative step count (calculated on each post-operative week) and mean pre-operative step count (calculated on 7 days before surgery). | 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Number of days of crutches use | until end of rehabilitation (+- 3 months after TKA operation) | ||
Secondary | Resume driving a car | Number of days post-operative | until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Overall Net Promotor Score (NPS) of the rehabilitation in general | NPS = How likely would you recommend the rehabilitation to your friends or family?". Visual analogue scale (VAS), a 0-100 scale with 100 score = very likely and 0 = not likely | 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation) | |
Secondary | Satisfaction and feedback on the geko device (only for patients using the geko) | Including:
Ease of use Required level of stimulation (1 to 11) Adherence to the geko use: daily collection of number of hours worn during the 10 days the geko device is used |
during 10 days after TKA operation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03895489 -
Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses
|
N/A | |
Completed |
NCT03660943 -
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
|
Phase 3 | |
Completed |
NCT04531969 -
Comparison of Outpatient and Inpatient Spa Therapy
|
N/A | |
Completed |
NCT02848027 -
Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment
|
Phase 3 | |
Completed |
NCT05160246 -
The Instant Effect of Kinesiology Taping in Patients With Knee OA
|
N/A | |
Recruiting |
NCT06080763 -
Biomechanics and Clinical Outcomes in Responders and Non-Responders
|
||
Completed |
NCT03643588 -
The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain
|
N/A | |
Active, not recruiting |
NCT05100225 -
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis
|
Phase 2 | |
Active, not recruiting |
NCT04061733 -
New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis
|
N/A | |
Completed |
NCT04051489 -
A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
|
||
Recruiting |
NCT05546541 -
Epidemiology and Nutrition
|
||
Recruiting |
NCT05447767 -
Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg
|
Phase 2 | |
Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
Not yet recruiting |
NCT03225911 -
Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis
|
N/A | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Completed |
NCT05703087 -
Positive Cueing in Knee Arthroplasty.
|
N/A | |
Not yet recruiting |
NCT06042426 -
Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population
|
Phase 4 | |
Completed |
NCT02944448 -
A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
|
Phase 2 | |
Not yet recruiting |
NCT02865174 -
Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT03037489 -
A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients
|
Phase 2 |